Liraglutide - overview of the preclinical and clinical data and its role in the treatment of type 2 diabetes
Author:
Publisher
Wiley
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1463-1326.2010.01330.x/fullpdf
Reference81 articles.
1. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustments of therapy: a consensus statement of the American Diabetes Association and the European Association for Study of Diabetes.;Nathan;Diabetes Care,2009
2. β-cell failure in diabetes and preservation by clinical treatment.;Wajchenberg;Endocr Rev,2007
3. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34).;UK Prospective Diabetes Study (UKPDS) Group.;Lancet,1998
4. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.;Kahn;N Engl J Med,2006
5. Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: UK Prospective Diabetes Study (UKPDS 55).;Davis;Diabetes Care,2001
Cited by 63 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Liraglutide innovations: a comprehensive review of patents (2014–2024);Pharmaceutical Patent Analyst;2024-07-16
2. Effect of tirzepatide on glycaemic control and weight loss compared with other glucagon‐like peptide‐1 receptor agonists in Japanese patients with type 2 diabetes mellitus;Diabetes, Obesity and Metabolism;2023-10-12
3. Emerging Role of GLP-1 Agonists in Obesity: A Comprehensive Review of Randomised Controlled Trials;International Journal of Molecular Sciences;2023-06-21
4. Safety, pharmacokinetics, and pharmacodynamics of TG103, a novel long-acting GLP-1/Fc fusion protein after a single ascending dose in Chinese healthy subjects;European Journal of Pharmaceutical Sciences;2023-06
5. Improved metabolic efficacy of a dual amylin and calcitonin receptor agonist when combined with semaglutide or empagliflozin;European Journal of Pharmacology;2023-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3